John William Ferkany
Keine laufenden Positionen mehr
Profil
John William Ferkany worked as Vice President-Development at Surface Logix LLC from 2005 to 2012.
He also held positions as Chief Technical Officer & Vice President at NovaScreen Biosciences Corp., Vice President at Virtual Drug Development, Inc., and Principal at Nova Pharmaceutical Corp.
Ferkany earned a doctorate degree from The University of Texas at Austin, a graduate degree from The Johns Hopkins University, and an undergraduate degree from the University of Michigan.
Ehemalige bekannte Positionen von John William Ferkany
| Unternehmen | Position | Ende |
|---|---|---|
Surface Logix LLC
 Surface Logix LLC Pharmaceuticals: MajorHealth Technology Surface Logix LLC is a drug development company which involves biophysical chemistry to create new small molecule drugs. It creates chemical entities and focuses on cardiovascular and metabolic diseases. The company was founded by George M. Whitesides and Carmichael S. Roberts, Jr. and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 03.10.2012 |
| Nova Pharmaceutical Corp. | Corporate Officer/Principal | - |
NovaScreen Biosciences Corp.
 NovaScreen Biosciences Corp. Miscellaneous Commercial ServicesCommercial Services Part of Revvity, Inc., NovaScreen Biosciences Corp. is a company that develops commercial research and drug discovery devices. The company is based in Hanover, MD. NovaScreen Biosciences was acquired by Caliper Life Sciences, Inc., part of Revvity, Inc. from November 07, 2011 on October 04, 2005 for $30 million. | Technik-/Wissenschafts-/F&E-Leiter | - |
Virtual Drug Development, Inc.
 Virtual Drug Development, Inc. Pharmaceuticals: MajorHealth Technology Virtual Drug Development, Inc. manufactures pharmaceutical preparations. Its product development areas include acute coronary syndrome, PCI, antifungal, antimicrobial, anthrax, NAD synthetase inhibitors for anthrax infections, agro-terrorism, new peptide pharmaceuticals announcement and InterLink, and biotechnologies. The company was founded by Stephen R. Porter and Kristen K. Flaharty and is headquartered in Brentwood, TN. | Corporate Officer/Principal | - |
Ausbildung von John William Ferkany
| The University of Texas at Austin | Doctorate Degree |
| The Johns Hopkins University | Graduate Degree |
| University of Michigan | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Surface Logix LLC
Surface Logix LLC Pharmaceuticals: MajorHealth Technology Surface Logix LLC is a drug development company which involves biophysical chemistry to create new small molecule drugs. It creates chemical entities and focuses on cardiovascular and metabolic diseases. The company was founded by George M. Whitesides and Carmichael S. Roberts, Jr. and is headquartered in Cambridge, MA. | Health Technology |
NovaScreen Biosciences Corp.
NovaScreen Biosciences Corp. Miscellaneous Commercial ServicesCommercial Services Part of Revvity, Inc., NovaScreen Biosciences Corp. is a company that develops commercial research and drug discovery devices. The company is based in Hanover, MD. NovaScreen Biosciences was acquired by Caliper Life Sciences, Inc., part of Revvity, Inc. from November 07, 2011 on October 04, 2005 for $30 million. | Commercial Services |
Virtual Drug Development, Inc.
Virtual Drug Development, Inc. Pharmaceuticals: MajorHealth Technology Virtual Drug Development, Inc. manufactures pharmaceutical preparations. Its product development areas include acute coronary syndrome, PCI, antifungal, antimicrobial, anthrax, NAD synthetase inhibitors for anthrax infections, agro-terrorism, new peptide pharmaceuticals announcement and InterLink, and biotechnologies. The company was founded by Stephen R. Porter and Kristen K. Flaharty and is headquartered in Brentwood, TN. | Health Technology |
| Nova Pharmaceutical Corp. |
